- cafead   Mar 24, 2022 at 09:02: PM
via The good news for Sun Pharma is that it's closed the books on one more legal problem it inherited from its Ranbaxy Laboratories buyout eight years ago. The bad: It's going to cost the generics maker $485 million.
article source
article source